Literature DB >> 13585064

Studies with dried and glycerinated smallpox vaccines of full and diminished potencies.

R M CROSS, C KAPLAN, D McCLEAN.   

Abstract

In a further vaccination and laboratory study with two dried smallpox vaccines (designated "P" and "Q") and one glycerinated vaccine, the potency of samples of each vaccine was deliberately lowered by exposure to heat. Groups of volunteers were vaccinated with the fully potent vaccines and with those of reduced potency. All subjects who developed a vesicular response were challenged one year later by revaccination with a potent vaccine, and the results obtained in the different groups were compared. No significant variation could be detected in the response of the different groups to the challenge vaccination. These findings indicate that if vesiculation is obtained with a vaccine, even though potency has been reduced to a point where it produces less than 50% successful primary vaccinations, satisfactory protection will result one year later. It also appears that successful vaccination with a dried vaccine confers as good immunity as that obtained from glycerinated lymph. Vaccines with a pock count of 10(6) infective units per millilitre will produce about 40% successes in primary vaccination.

Entities:  

Keywords:  SMALLPOX/immunology

Mesh:

Substances:

Year:  1958        PMID: 13585064      PMCID: PMC2537703     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  2 in total

1.  Laboratory and vaccination studies with dried smallpox vaccines.

Authors:  W C COCKBURN; R M CROSS; A W DOWNIE; K R DUMBELL; C KAPLAN; D MCCLEAN; A M PAYNE
Journal:  Bull World Health Organ       Date:  1957       Impact factor: 9.408

2.  The heat resistance of dried smallpox vaccine.

Authors:  R M CROSS; C KAPLAN; D MCCLEAN
Journal:  Lancet       Date:  1957-03-02       Impact factor: 79.321

  2 in total
  4 in total

1.  Relationship between pock counts on chorio-allantoic membrane and percentages of "takes" in primary vaccination of human beings with two smallpox vaccines.

Authors:  M F POLAK; L M BRANS; J BEUNDERSB; A van der WERFF
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

2.  Protective immunity following vaccination: how is it defined?

Authors:  Ian J Amanna; Ilhem Messaoudi; Mark K Slifka
Journal:  Hum Vaccin       Date:  2008-02-19

3.  Take rates by double versus single insertions of smallpox vaccine in revaccinees.

Authors:  J M Lane; T M Mack; J D Millar
Journal:  Public Health Rep       Date:  1970-10       Impact factor: 2.792

Review 4.  LC16m8: an attenuated smallpox vaccine.

Authors:  Julie Kenner; Fiona Cameron; Cyril Empig; David V Jobes; Marc Gurwith
Journal:  Vaccine       Date:  2006-04-21       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.